8.19
+0.01
+(0.12%)
At close: January 27 at 3:04:10 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
748,045.83
952,970.90
698,977.61
592,171.63
464,796.38
Operating Cash Flow
--
952,970.90
698,977.61
592,171.63
464,796.38
Investing Cash Flow
-201,572.01
-617,271.61
-543,883.00
-171,098.91
-363,351.36
Financing Cash Flow
-440,065.39
-400,994.10
-153,151.41
-276,302.32
-126,351.41
End Cash Position
350,530.76
258,783.95
324,186.08
322,179.79
177,423.98
Capital Expenditure
-152,307.15
-195,335.59
-474,339.69
-131,229.76
-138,523.79
Issuance of Debt
--
--
3,000.00
--
--
Repayment of Debt
--
-3,030.00
--
-14,000.00
-14,000.00
Free Cash Flow
595,738.68
757,635.31
224,637.91
460,941.86
326,272.59
12/31/2020 - 10/30/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
300122.SZ Chongqing Zhifei Biological Products Co., Ltd.
24.09
-0.90%
3759.HK Pharmaron Beijing Co., Ltd.
14.100
-1.40%
2696.HK Shanghai Henlius Biotech, Inc.
16.760
-1.41%
2269.HK WuXi Biologics (Cayman) Inc.
18.420
-0.22%
SVRA Savara Inc.
2.8000
+4.87%
CABA Cabaletta Bio, Inc.
2.3400
-1.27%
UBX Unity Biotechnology, Inc.
2.1400
-4.46%
TLSA Tiziana Life Sciences Ltd
0.6879
-1.95%
DWTX Dogwood Therapeutics, Inc.
12.76
+6.24%